Literature DB >> 1887921

Influence of metabolic substrate on rat heart function and metabolism at different coronary flows.

D Burkhoff1, R G Weiss, S P Schulman, R Kalil-Filho, T Wannenburg, G Gerstenblith.   

Abstract

The influence of metabolic substrate on contractile strength, myocardial oxygen consumption (MVO2), high- and low-energy phosphate levels, and intracellular pH were determined in isovolumically contracting isolated rat hearts perfused with solutions containing either glucose or hexanoate at both high and low coronary perfusion pressures (CPP). Contractile strength was not significantly influenced by substrate at a CPP of 80 mmHg. As coronary flow was decreased, developed pressure measured at a fixed left ventricular volume (LVV) was lower during hexanoate than glucose perfusion. The relationship between MVO2 and mechanical work determined at a CPP of 80 mmHg over a range of LVVs was shifted upward in a parallel manner when substrate was switched from glucose to hexanoate. The MVO2-work relationship measured at a fixed LVV but over a range of coronary flows (7-20 ml/min) was also parallel shifted upward on switching from glucose to hexanoate. Basal MVO2 was greater during hexanoate than glucose perfusion by an amount that accounted for two-thirds the total increase in MVO2 observed between the substrates under unloaded beating conditions. The remainder of the difference was attributed to increased energy requirements for excitation-contraction coupling. Inorganic phosphate concentrations increased more and phosphocreatine concentrations decreased more during low-flow conditions (3 ml/min) when hearts were perfused with hexanoate compared with glucose. Thus hexanoate decreases myocardial efficiency compared with glucose in large part by increasing non-work-related oxygen demands. This inefficiency impacts adversely on contractile strength and high-energy phosphate concentrations at low coronary flows.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1887921     DOI: 10.1152/ajpheart.1991.261.3.H741

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery.

Authors:  D Gonsolin; K Couturier; B Garait; S Rondel; V Novel-Chaté; S Peltier; P Faure; P Gachon; Y Boirie; C Keriel; R Favier; S Pepe; L Demaison; X Leverve
Journal:  Mol Cell Biochem       Date:  2006-08-31       Impact factor: 3.396

2.  Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.

Authors:  Saifudeen Ismael; Sreeja Purushothaman; V S Harikrishnan; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

Review 3.  Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

Authors:  Brian O'Rourke; Jennifer E Van Eyk; D Brian Foster
Journal:  Congest Heart Fail       Date:  2011-11-09

Review 4.  Energy metabolism in the normal and failing heart: potential for therapeutic interventions.

Authors:  William C Stanley; Margaret P Chandler
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  Differential effects of AMP-activated protein kinase in isolated rat atria subjected to simulated ischemia-reperfusion depending on the energetic substrates available.

Authors:  Romina Hermann; Victoria Evangelina Mestre Cordero; María de Las Mercedes Fernández Pazos; Federico Joaquín Reznik; Débora Elisabet Vélez; Enrique Alberto Savino; María Gabriela Marina Prendes; Alicia Varela
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

6.  Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

Authors:  Sebastian Obrzut; Jay Tiongson; Neema Jamshidi; Huy Minh Phan; Carl Hoh; Ulrika Birgersdotter-Green
Journal:  J Cardiovasc Transl Res       Date:  2010-09-15       Impact factor: 4.132

7.  Myocardial glucose and lactate metabolism during rest and atrial pacing in humans.

Authors:  Bryan C Bergman; Tatiana Tsvetkova; Brian Lowes; Eugene E Wolfel
Journal:  J Physiol       Date:  2009-03-16       Impact factor: 5.182

8.  Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation.

Authors:  Ashwin Akki; Katie Smith; Anne-Marie L Seymour
Journal:  Mol Cell Biochem       Date:  2008-02-16       Impact factor: 3.396

9.  Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase.

Authors:  B Clarke; M Spedding; L Patmore; J G McCormack
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 10.  Cardiac efficiency.

Authors:  J D Schipke
Journal:  Basic Res Cardiol       Date:  1994 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.